Enzo, Weizmann Institute of Science cancer, infectious news

The U.S. Patent and Trademark Office declared an interference between a patent application for interleukin-6 (IL-6) owned by ENZ's Enzo Therapeutics Inc. subsidiary and four U.S. patents owned by Yed...